Bronchial asthma: assessment of knowledge among therapeutic profile physicians during continuing education courses

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The urgency of the problem is due to the need to implement the current clinical guidelines, as well as modern approaches to the treatment and prevention of bronchial asthma (BA), proposed by the GINA (Global Strategy for Asthma Management and Prevention) expert committee into the practice of physicians. There are many offers of training courses available on the Internet, which often do not give the expected results. This study presents the results of a two-stage testing of participants in the advanced training cycle (37 physicians of therapeutic profile from the Republic of Mari El) using research questionnaires within the ASSA-IV multicenter project «ASSA» («Assessment of senior medical students in the field of bronchial asthma ») to assess the baseline level of knowledge on the etiology, pathogenesis, diagnosis, and pharmacotherapy of BA. Descriptive statistics methods were used, and group comparisons were conducted using the Wilcoxon test. The proportion of correct answers of responses was 64.2 % (95% CI: 60.8–67.6%) in the first stage and 89.6% (95% CI: 85.6–93.1%) in the second stage. The Wilcoxon criterion for difference in mean was 664.5, which was statistically highly significant (p<0.001). The median value increased from 67% (Q1–Q3: 57–71%) to 90% (Q1–Q3: 8.5–100%). The greatest progress in average level of the proportion of correct answers values was observed in questions related to the etiology of BA (+31.6%; p<0.001 – question 1), BA pharmacotherapy (+59.5%; p<0.001 – question 14; +46%; p<0.001 – question 17; +67.6%; p<0.001 – question 18; +50%; p<0.001 – question 19). The findings confirm the necessity for physicians to regularly complete continuing medical education courses, prioritizing state-accredited educational institutions.

Full Text

Restricted Access

About the authors

R. A. Bontsevich

Mari State University; Belgorod National Research University; Kazan State Medical Academy – Branch of the Russian Medical Academy of Continuous Professional Education

Author for correspondence.
Email: bontsevich_ra@marsu.ru
ORCID iD: 0000-0002-9328-3905
SPIN-code: 5336-7800

Associate Professor, Candidate of Medical Sciences

 

Russian Federation, Yoshkar-Ola; Belgorod; Kazan

A. V. Mikhailov

Mari State University

Email: bontsevich_ra@marsu.ru
ORCID iD: 0009-0002-0299-3272
SPIN-code: 3548-0136
Russian Federation, Yoshkar-Ola

A. O. Pirogova

Mari State University

Email: bontsevich_ra@marsu.ru
ORCID iD: 0009-0000-8221-3349
Russian Federation, Yoshkar-Ola

A. A. Fyodorova

Mari State University

Email: bontsevich_ra@marsu.ru
ORCID iD: 0009-0002-0771-0243
Russian Federation, Yoshkar-Ola

E. O. Pakeeva

Mari State University

Email: bontsevich_ra@marsu.ru
ORCID iD: 0009-0001-6284-5362
Yoshkar-Ola

M. L. Maksimov

Kazan State Medical Academy – Branch of the Russian Medical Academy of Continuous Professional Education; Russian Medical Academy of Continuous Professional Education; N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia

Email: bontsevich_ra@marsu.ru
ORCID iD: 0000-0002-8979-8084
SPIN-code: 6261-3982

Professor, MD

Russian Federation, Kazan; Moscow; Moscow

References

  1. Российская ассоциация аллергологов и клинических иммунологов. Российское респираторное общество. Союз педиатров России. Ассоциация врачей и специалистов медицины труда. Бронхиальная астма. Клинические рекомендации 2024 [Russian Association of Allergologists and Clinical Immunologists. Russian Respiratory Society. Union of Pediatricians of Russia. Association of Physicians and Specialists in Occupational Medicine. Bronchial asthma. Clinical recommendations 2024 (in Russ.)]. URL: https://spulmo.ru/upload/KR-bronhialnaya-astma-2024.pdf
  2. Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention (2024). URL: https://ginasthma.org/2024-report/
  3. Сулайманов Ш.А., Ашералиев М.Е., Муратова Ж.К. и др. GINA-2024: ключевые изменения и подходы к таргетной терапии. Бюллетень науки и практики. 2024; 10 (7): 259–68 [Suleimanov, S.A., Asheraliev, M.E., Muratova, Zh.K. et al. GINA-2024: Key modifications and strategic implementations for targeted therapeutic interventions. Bulletin of Science and Practice. 2024; 10 (7): 259–68. (in Russ.)]. doi: 10.33619/2414-2948/104/27
  4. World Health Organization. Asthma. 2024. URL: https://www.who.int/ru/news-room/fact-sheets/detail/asthma
  5. U.S. Centers for Disease Control and Prevention. Asthma Data. 2024. URL: https://www.cdc.gov/asthma-data/about/most-recent-asthma-data.html
  6. Chuchalin A.G., Khaltaev N., Antonov N.S. et al. Chronic respiratory diseases and risk factors in 12 regions of the Russian Federation. Int J Chron Obstruct Pulmon Dis. 2014; 9: 963–74. doi: 10.2147/COPD.S67283
  7. Сыров В.В. Представление об эпидемиологии и возможностях профилактики бронхиальной астмы на современном этапе. Аллергология и иммунология в педиатрии. 2016; 3 (46): 20–33 [Syrov V.V. The concepts of epidemiology and prevention capabilities of asthma at the present stage. Allergology and Immunology in Pediatrics. 2016; 3 (46): 20–33 (in Russ.)]. doi: 10.24411/2500-1175-2016-00017
  8. Пивень Д.В., Кицул И.С. Риски повышения квалификации врачей в частных образовательных организациях: причины, последствия, что делать. Менеджер здравоохранения. 2023; 5: 13–20 [Piven D.V., Kitsul I.S. Risks of advanced training of doctors in private educational institutions: causes, consequences, what to do. Manager Zdravoohranenia. 2023; 5: 13–20 (in Russ.)]. doi: 10.21045/1811-0185-2023-5-13-20
  9. Бонцевич Р.А. Образовательная фармакоэпидемиология и «знания из реальной практики». Реальная клиническая практика: данные и доказательства. 2024; 4 (4): 44–52 [Bontsevich R.A. Educational pharmacoepidemiology and "Real-World Knowledge". Real-World Data & Evidence. 2024; 4 (4): 44–52 (in Russ.)]. doi: 10.37489/2782-3784-myrwd-062
  10. Бонцевич Р.А., Землянская О.И., Михно А.В. и др. Итоговые результаты исследования ASSA-II: знания врачей терапевтического профиля по бронхиальной астме. Научные результаты биомедицинских исследований. 2020; 6 (3): 367–83 [Bontsevich R.A., Zemlyanskaya O.I., Mikhno A.V. et al. The final results of the ASSA-II study: the knowledge of therapeutic doctors on the subject of bronchial asthma. Research Results in Biomedicine. 2020; 6 (3): 367–83 (in Russ.)]. doi: 10.18413/2658-6533-2020-6-3-0-7
  11. Бонцевич Р.А., Водяхина А.Я., Умеренков А.А. и др. Бронхиальная астма – фармакоэпидемиологический срез знаний врачей. Вестник современной клинической медицины. 2024; 17 (2): 23–33 [Bontsevich R.A., Vodyakhina A.Y., Umerenkov A.A. et al. Bronchial asthma: Physicians' pharmacoepidemiologic knowledge assessment. ASSA-III Results. The Bulletin of Contemporary Clinical Medicine. 2024; 17 (2): 23–33 (in Russ.)]. doi: 10.20969/VSKM.2024.17(2).23-33
  12. Бонцевич Р.А., Водяхина А.Я., Батищева Г.А. и др. Оценка знаний студентов старших курсов по бронхиальной астме. Бюллетень физиологии и патологии дыхания. 2023; 90: 29–38 [Bontsevich R.A., Vodyakhina A.Y., Batishcheva G.A. et al. Assessment of knowledge of senior students on bronchial asthma. Results of the ASSA-III study. Bulletin Physiology and Pathology of Respiration. 2023; 90: 29–38 (in Russ.)]. doi: 10.36604/1998-5029-2023-90-29-38
  13. Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention (2019). URL: https://ginasthma.org/2019-report/
  14. Авдеев С.Н., Ненашева Н.М., Жуденков К.В. и др. Распространенность, заболеваемость, фенотипы и другие характеристики тяжелой бронхиальной астмы в Российской Федерации. Пульмонология. 2018; 28 (3): 341–58 [Avdeev S.N., Nenasheva N.M., Zhudenkov K.V. et al. Prevalence, morbidity, phenotypes and other characteristics of severe bronchial asthma in Russian Federation. Pulmonologiya. 2018; 28 (3): 341–58 (in Russ.)]. doi: 10.18093/0869-0189-2018-28-3-341-358
  15. Российское респираторное общество. Бронхиальная астма. Клинические рекомендации. 2019 [Russian Respiratory Society. Bronchial asthma: Clinical guidelines. 2019 (in Russ.)]. URL: https://spulmo.ru/upload/kr_bronhastma_2019.pdf
  16. Белевский А.С. Современная терапия бронхиальной астмы, шаг вперед. Астма и аллергия. 2013; 3: 16–9 [Belevsky AS. Modern therapy for bronchial asthma: a step forward. Asthma and Allergy. 2013; 3: 16–9 (in Russ.)].
  17. Reddel H.K., Bateman E.D., Schatz M. et al. A Practical Guide to Implementing SMART in Asthma Management. J Allergy Clin Immunol Pract. 2022; 10 (1S): S31–S38. doi: 10.1016/j.jaip.2021.10.011
  18. Ichinose M., Sugiura H., Nagase H. et al. Japanese guidelines for adult asthma 2017. Allergol Int. 2017; 66 (2): 163–89. doi: 10.1016/j.alit.2016.12.005

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Fig. 1. Levels of correct answers in stages 1 and 2 of the study (median, Q1–Q3, min-max, % are given)

Download (76KB)
3. Fig. 2. Information on quantitative fields at stages 1 and 2 of the study

Download (134KB)
4. Fig. 3. Comparison of correct answer rates for identical questions with highly significant changes between study stages (p<0.001)

Download (64KB)

Copyright (c) 2025 Russkiy Vrach Publishing House